MARY CORGAN: Open Payments
NPI 1255664280 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$949 in 8 payments from 8 companies in 2025. Trend: 2023 $821 · 2024 $387 · 2025 $949
Food & beverage: $949
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $149 |
| Madrigal Pharmaceuticals | 1 | $138 |
| Dexcom, Inc. | 1 | $136 |
| Recor Medical Inc | 1 | $130 |
| Novo Nordisk Inc | 1 | $125 |
| Pacira Pharmaceuticals Incorporated | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $124 |
| Kestra Medical Technology Services, Inc. | 1 | $22 |
Products named: REZDIFFRA, DEXCOM G7 GSS (161), Paradise Ultrasound Renal Denervation System, Wegovy, Iovera, COBENFY, Assure WCD.
Industry payments across MO — which companies pay providers there.
